Mobile

A double-blind, randomised, placebo-controlled, parallel group study to investigate the effects of SB-742457, donepezil and placebo on cognition in subjects with mild to moderate Alzheimer's Disease

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-000468-95

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To investigate the effects in subjects with mild-to-moderate probable Alzheimer’s disease on cognitive and global functioning of once daily dosing of SB-742457 and donepezil versus placebo after 24 weeks of treatment.

Critère d'inclusion

  • Alzheimer's disease

Liens